GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HAEMATO AG (XTER:HAEK) » Definitions » Cyclically Adjusted PS Ratio

HAEMATO AG (XTER:HAEK) Cyclically Adjusted PS Ratio : 0.18 (As of May. 26, 2024)


View and export this data going back to 2005. Start your Free Trial

What is HAEMATO AG Cyclically Adjusted PS Ratio?

As of today (2024-05-26), HAEMATO AG's current share price is €21.40. HAEMATO AG's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec22 was €119.32. HAEMATO AG's Cyclically Adjusted PS Ratio for today is 0.18.

The historical rank and industry rank for HAEMATO AG's Cyclically Adjusted PS Ratio or its related term are showing as below:

XTER:HAEK' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.13   Med: 0.3   Max: 1.3
Current: 0.13

During the past 13 years, HAEMATO AG's highest Cyclically Adjusted PS Ratio was 1.30. The lowest was 0.13. And the median was 0.30.

XTER:HAEK's Cyclically Adjusted PS Ratio is ranked better than
96.23% of 743 companies
in the Drug Manufacturers industry
Industry Median: 2.11 vs XTER:HAEK: 0.13

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

HAEMATO AG's adjusted revenue per share data of for the fiscal year that ended in Dec22 was €47.455. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €119.32 for the trailing ten years ended in Dec22.

Shiller PE for Stocks: The True Measure of Stock Valuation


HAEMATO AG Cyclically Adjusted PS Ratio Historical Data

The historical data trend for HAEMATO AG's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HAEMATO AG Cyclically Adjusted PS Ratio Chart

HAEMATO AG Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.62 0.35 0.24 0.23 0.14

HAEMATO AG Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.23 - 0.14 -

Competitive Comparison of HAEMATO AG's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, HAEMATO AG's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HAEMATO AG's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, HAEMATO AG's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where HAEMATO AG's Cyclically Adjusted PS Ratio falls into.



HAEMATO AG Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

HAEMATO AG's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=21.40/119.32
=0.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HAEMATO AG's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec22 is calculated as:

For example, HAEMATO AG's adjusted Revenue per Share data for the fiscal year that ended in Dec22 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec22 (Change)*Current CPI (Dec22)
=47.455/119.3449*119.3449
=47.455

Current CPI (Dec22) = 119.3449.

HAEMATO AG Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201312 88.645 99.356 106.479
201412 97.533 99.543 116.936
201512 110.552 99.717 132.313
201612 132.634 101.217 156.389
201712 134.810 102.617 156.786
201812 122.266 104.217 140.013
201912 86.504 105.818 97.562
202012 99.804 105.518 112.883
202112 55.946 110.384 60.488
202212 47.455 119.345 47.455

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


HAEMATO AG  (XTER:HAEK) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


HAEMATO AG Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of HAEMATO AG's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


HAEMATO AG (XTER:HAEK) Business Description

Industry
Traded in Other Exchanges
Address
Lilienthalstrasse 5c, Schonefeld, DEU, D-12529
HAEMATO AG is a Germany based pharmaceutical company. It provides pharmaceuticals for the care of chronically ill people. The firm is engaged in the sale of generic and EU (European countries) import drugs. It is focused on patented and non-patented medicinal products. The company product portfolio includes human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), neurology, oncology, rheumatology, and urology. Geographically, it operates only in Germany.

HAEMATO AG (XTER:HAEK) Headlines

No Headlines